InterVenn BioSciences Raises Institutional Round to Help Physicians Detect Early Ovarian Cancer With a Minimally Invasive Test | Read more

Partnerships

Partner with us to chart the next frontier of precision medicine

We use our proprietary mass spectrometry workflow, computational biology, and information technology capabilities to provide our partners with comprehensive proteomic and epiproteomic profiling tools.

Academic & Research Institutions

Biopharmaceutical Companies

BIOMARKER AND PATHWAY DISCOVERY

We collaborate with academic and pharmaceutical partners to elucidate new molecular pathways leading to disease, by combining high resolution mass spectrometry, glycobiology insights, multi-omic analyses and bioinformatics.

DRUG DEVELOPMENT & CLINICAL TRIAL DESIGN

We support drug development and clinical trial success by providing epiproteomic and glycoproteomic profiling tools to pharmaceutical companies. We provide analyses of retrospectively and prospectively collected serum / plasma samples to enable patient stratification and selection, efficacy and treatment monitoring, and development of companion diagnostics.

Learn more about how we can work together

Please fill out the form below or email us at partnering@venn.bio